(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) has closed its investigation on Abbott Laboratories’ infant formula, with no additional cases of infections, according to a notice on the U.S. Food and Drug Administration website.
The agencies were investigating bacterial infections caused by the infant formula manufactured at Abbott’s Sturgis facility in Michigan.
(Reporting by Leroy Leo in Bengaluru; Editing by Krishna Chandra Eluri)
